Rapid high-performance liquid chromatographic determination of cefepime in human plasma

被引:3
作者
Calahorra, B [1 ]
Campanero, MA [1 ]
Sádaba, B [1 ]
Azanza, JR [1 ]
机构
[1] Univ Navarra Clin, Dept Clin Pharmacol, Pamplona 31008, Spain
关键词
D O I
10.1002/(SICI)1099-0801(199906)13:4<272::AID-BMC842>3.0.CO;2-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple, rapid and reproducible-high-performance liquid chromatographic method for the quantitative determination of cefepime in human plasma was developed. Ceftazidime was used as internal standard. Chromatography was performed on a reversed-phase encapped column (Hypersil BDS C-18) The samples, after protein precipitation, were eluted with a mobile phase of acetonitrile-acetate buffer, pH 4 (2.8:97.2, v/v). The detection wavelength was 254 nm. The limit of quantitation of cefepime was 0.5 mu g/mL and only 0.5 mt of plasma sample was required for the determination. The average cefepime recoveries over a concentration range of 0.5-500 mu g/mL ranged from 98 to 104%. Precision and accuracy did not exceed 5%. Copyright (C) 1999 John Wiley & Sons, Ltd.
引用
收藏
页码:272 / 275
页数:4
相关论文
共 12 条
[1]   HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC ANALYSIS OF BMY-28142 IN PLASMA AND URINE [J].
BARBHAIYA, RH ;
FORGUE, ST ;
SHYU, WC ;
PAPP, EA ;
PITTMAN, KA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) :55-59
[2]   PHARMACOKINETICS OF CEFEPIME AFTER SINGLE AND MULTIPLE INTRAVENOUS ADMINISTRATIONS IN HEALTHY-SUBJECTS [J].
BARBHAIYA, RH ;
FORGUE, ST ;
GLEASON, CR ;
KNUPP, CA ;
PITTMAN, KA ;
WEIDLER, DJ ;
MOVAHHED, H ;
TENNEY, J ;
MARTIN, RR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) :552-557
[3]   CEFEPIME - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].
BARRADELL, LB ;
BRYSON, HM .
DRUGS, 1994, 47 (03) :471-505
[4]   PHARMACOKINETICS OF CEFEPIME DIHYDROCHLORIDE ARGININE IN SUBJECTS WITH RENAL IMPAIRMENT [J].
CRONQVIST, J ;
NILSSONEHLE, I ;
OQVIST, B ;
NORRBY, SR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) :2676-2680
[5]  
DOLAN JW, 1992, LC GC EUR, V5, P16
[6]   High-performance liquid chromatographic assay for cefepime in serum [J].
Elkhaili, H ;
Linger, L ;
Monteil, H ;
Jehl, F .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1997, 690 (1-2) :181-188
[7]   HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC ANALYSIS FOR QUANTITATION OF BMY-28142 AND CEFTAZIDIME IN HUMAN AND RABBIT SERUM [J].
FASCHING, CE ;
PETERSON, LR ;
GERDING, DN .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1986, 9 (08) :1803-1814
[8]  
KALMAN D, 1992, ANTIMICROB AGENTS CH, V36, P435
[9]   PHARMACOKINETICS OF CEFEPIME IN PATIENTS WITH THE SEPSIS SYNDROME [J].
KIEFT, H ;
HOEPELMAN, AIM ;
KNUPP, CA ;
VANDIJK, A ;
BRANGER, JM ;
STRUYVENBERG, A ;
VERHOEF, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 :117-122
[10]   CEFEPIME CLINICAL PHARMACOKINETICS [J].
OKAMOTO, MP ;
NAKAHIRO, RK ;
CHIN, A ;
BEDIKIAN, A .
CLINICAL PHARMACOKINETICS, 1993, 25 (02) :88-102